Geron Corp. (GERN)
0.8707
-0.04
(-4.63%)
USD |
NASDAQ |
Nov 20, 16:00
0.8696
0.00 (0.00%)
After-Hours: 20:00
Geron Net Income (Quarterly) : 1.35M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.35M |
| June 30, 2026 | -16.68M |
| March 31, 2026 | -3.642M |
| December 31, 2025 | -31.14M |
| September 30, 2025 | -18.43M |
| June 30, 2025 | -16.38M |
| March 31, 2025 | -19.84M |
| December 31, 2024 | -25.35M |
| September 30, 2024 | -26.45M |
| June 30, 2024 | -67.38M |
| March 31, 2024 | -55.39M |
| December 31, 2023 | -51.97M |
| September 30, 2023 | -44.80M |
| June 30, 2023 | -49.23M |
| March 31, 2023 | -38.12M |
| December 31, 2022 | -42.64M |
| September 30, 2022 | -41.05M |
| June 30, 2022 | -28.12M |
| March 31, 2022 | -30.10M |
| December 31, 2021 | -32.02M |
| September 30, 2021 | -26.70M |
| June 30, 2021 | -29.57M |
| March 31, 2021 | -27.82M |
| December 31, 2020 | -23.79M |
| September 30, 2020 | -19.65M |
| Date | Value |
|---|---|
| June 30, 2020 | -15.82M |
| March 31, 2020 | -16.36M |
| December 31, 2019 | -29.07M |
| September 30, 2019 | -15.18M |
| June 30, 2019 | -14.24M |
| March 31, 2019 | -10.06M |
| December 31, 2018 | -7.30M |
| September 30, 2018 | -5.597M |
| June 30, 2018 | -6.934M |
| March 31, 2018 | -7.186M |
| December 31, 2017 | -7.429M |
| September 30, 2017 | -6.899M |
| June 30, 2017 | -6.405M |
| March 31, 2017 | -7.183M |
| December 31, 2016 | -8.482M |
| September 30, 2016 | -3.576M |
| June 30, 2016 | -8.637M |
| March 31, 2016 | -8.842M |
| December 31, 2015 | -8.468M |
| September 30, 2015 | 27.18M |
| June 30, 2015 | -9.356M |
| March 31, 2015 | -9.315M |
| December 31, 2014 | -8.947M |
| September 30, 2014 | -9.549M |
| June 30, 2014 | -8.734M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | -0.311M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -3.750M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 60.19M |
| Total Expenses (Quarterly) | 58.84M |
| EPS Diluted (Quarterly) | 0.002 |
| Enterprise Value | 522.84M |
| Gross Profit Margin (Quarterly) | 89.95% |
| Profit Margin (Quarterly) | 2.24% |
| Earnings Yield | -8.61% |
| Normalized Earnings Yield | -6.638 |